Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy. [electronic resource]
Producer: 20160407Description: 25 p. digitalISSN:- 1465-993X
- Administration, Inhalation
- Adrenal Cortex Hormones -- administration & dosage
- Adrenergic beta-2 Receptor Agonists -- administration & dosage
- Aged
- Androstadienes -- administration & dosage
- Bayes Theorem
- Benzyl Alcohols -- administration & dosage
- Bronchodilator Agents -- administration & dosage
- Budesonide, Formoterol Fumarate Drug Combination -- administration & dosage
- Chlorobenzenes -- administration & dosage
- Disease Progression
- Drug Administration Schedule
- Female
- Fluticasone-Salmeterol Drug Combination -- administration & dosage
- Forced Expiratory Volume
- Humans
- Lung -- drug effects
- Male
- Middle Aged
- Pulmonary Disease, Chronic Obstructive -- diagnosis
- Randomized Controlled Trials as Topic
- Recovery of Function
- Risk Factors
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.